Literature DB >> 17694419

Trends and disparities in regionalization of pancreatic resection.

Taylor S Riall1, Karl A Eschbach, Courtney M Townsend, William H Nealon, Jean L Freeman, James S Goodwin.   

Abstract

BACKGROUND: The current recommendation is that pancreatic resections be performed at hospitals doing >10 pancreatic resections annually.
OBJECTIVE: To evaluate the extent of regionalization of pancreatic resection and the factors predicting resection at high-volume centers (>10 cases/year) in Texas.
METHODS: Using the Texas Hospital Inpatient Discharge Public Use Data File, we evaluated trends in the percentage of patients undergoing pancreatic resection at high-volume centers (>10 cases/year) from 1999 to 2004 and determined the factors that independently predicted resection at high-volume centers.
RESULTS: A total of 3,189 pancreatic resections were performed in the state of Texas. The unadjusted in-hospital mortality was higher at low-volume centers (7.4%) compared to high-volume centers (3.0%). Patients resected at high-volume centers increased from 54.5% in 1999 to 63.3% in 2004 (P = 0.0004). This was the result of a decrease in resections performed at centers doing less than five resections/year (35.5% to 26.0%). In a multivariate analysis, patients who were >75 (OR = 0.51), female (OR = 0.86), Hispanic (OR = 0.58), having emergent surgery (OR = 0.39), diagnosed with periampullary cancer (OR = 0.68), and living >75 mi from a high-volume center (OR = 0.93 per 10-mi increase in distance, P < 0.05 for all OR) were less likely to be resected at high-volume centers. The odds of being resected at a high-volume center increased 6% per year.
CONCLUSIONS: Whereas regionalization of pancreatic resection at high-volume centers in the state of Texas has improved slightly over time, 37% of patients continue to undergo pancreatic resection at low-volume centers, with more than 25% occurring at centers doing less than five per year. There are obvious demographic disparities in the regionalization of care, but additional unmeasured barriers need to be identified.

Entities:  

Mesh:

Year:  2007        PMID: 17694419     DOI: 10.1007/s11605-007-0245-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

1.  Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality.

Authors:  A S Rosemurgy; M Bloomston; F M Serafini; B Coon; M M Murr; L C Carey
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

2.  Complex gastrointestinal surgery: impact of provider experience on clinical and economic outcomes.

Authors:  T A Gordon; H M Bowman; E B Bass; K D Lillemoe; C J Yeo; R F Heitmiller; M A Choti; G P Burleyson; G Hsieh; J L Cameron
Journal:  J Am Coll Surg       Date:  1999-07       Impact factor: 6.113

3.  Raising the bar for pancreaticoduodenectomy.

Authors:  John D Birkmeyer
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

4.  Volume and process of care in high-risk cancer surgery.

Authors:  John D Birkmeyer; Yating Sun; Aaron Goldfaden; Nancy J O Birkmeyer; Therese A Stukel
Journal:  Cancer       Date:  2006-06-01       Impact factor: 6.860

5.  Potential benefits of the new Leapfrog standards: effect of process and outcomes measures.

Authors:  John D Birkmeyer; Justin B Dimick
Journal:  Surgery       Date:  2004-06       Impact factor: 3.982

Review 6.  Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands.

Authors:  N Tjarda van Heek; Koert F D Kuhlmann; Rob J Scholten; Steve M M de Castro; Olivier R C Busch; Thomas M van Gulik; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

7.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

8.  The effects of regionalization on cost and outcome for one general high-risk surgical procedure.

Authors:  T A Gordon; G P Burleyson; J M Tielsch; J L Cameron
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

9.  Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial.

Authors:  Keith D Lillemoe; John L Cameron; Min P Kim; Kurtis A Campbell; Patricia K Sauter; Joann A Coleman; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

10.  A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas.

Authors:  J R Lange; S M Steinberg; G M Doherty; H N Langstein; D E White; T H Shawker; R C Eastman; R T Jensen; J A Norton
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

View more
  27 in total

1.  Pancreaticoduodenectomy in Florida: do 20-year trends document the salutary benefits of centralization of care?

Authors:  Carrie E Ryan; Thomas W Wood; Sharona B Ross; Amanda E Smart; Prashant B Sukharamwala; Alexander S Rosemurgy
Journal:  HPB (Oxford)       Date:  2015-08-07       Impact factor: 3.647

2.  Surgical specialization and operative mortality in hepato-pancreatico-biliary (HPB) surgery.

Authors:  Nicholas G Csikesz; Jessica P Simons; Jennifer F Tseng; Shimul A Shah
Journal:  J Gastrointest Surg       Date:  2008-07-09       Impact factor: 3.452

3.  Temporal trends in liver transplant centre volume in the USA.

Authors:  Elisabeth T Tracy; Kyla M Bennett; Emeline M Aviki; Theodore N Pappas; Bradley H Collins; Janet E Tuttle-Newhall; Carlos E Marroquin; Paul C Kuo; John E Scarborough
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

4.  Surgeon volume metrics in laparoscopic cholecystectomy.

Authors:  Nicholas G Csikesz; Anand Singla; Melissa M Murphy; Jennifer F Tseng; Shimul A Shah
Journal:  Dig Dis Sci       Date:  2009-11-13       Impact factor: 3.199

5.  What factors influence minority use of National Cancer Institute-designated cancer centers?

Authors:  Lyen C Huang; Yifei Ma; Justine V Ngo; Kim F Rhoads
Journal:  Cancer       Date:  2013-10-21       Impact factor: 6.860

6.  Estimating the need for hepato-pancreatico-biliary surgeons in the USA.

Authors:  Noaman Ali; Colin O'Rourke; Kevin El-Hayek; Sricharan Chalikonda; D Rohan Jeyarajah; R Matthew Walsh
Journal:  HPB (Oxford)       Date:  2014-12-29       Impact factor: 3.647

7.  National disparities in minimally invasive surgery for pancreatic tumors.

Authors:  Emmanuel Gabriel; Pragatheeshwar Thirunavukarasu; Kristopher Attwood; Steven J Nurkin
Journal:  Surg Endosc       Date:  2016-07-13       Impact factor: 4.584

8.  Regionalization and outcomes of hepato-pancreato-biliary cancer surgery in USA.

Authors:  Paul D Colavita; Victor B Tsirline; Igor Belyansky; Ryan Z Swan; Amanda L Walters; Amy E Lincourt; David A Iannitti; B Todd Heniford
Journal:  J Gastrointest Surg       Date:  2014-01-16       Impact factor: 3.452

9.  Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process.

Authors:  Taylor S Riall; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

10.  Readmission after pancreatectomy for pancreatic cancer in Medicare patients.

Authors:  Deepthi M Reddy; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin; Taylor S Riall
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.